Treatment of hyperproliferative diseases

Details Treatment of hyperproliferative diseases Treatment of hyperproliferative diseases

2002-02-27

2011-11-01

Royds Draper, Leslie A (Department: 1629)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

C514S569000

Reexamination Certificate

active

08048918

ABSTRACT:
We describe methods and compositions for treating a patient suffering from a hyperproliferative disorder or photoageing. Our methods involve blocking the activity of a retinol binding protein receptor (RBPr) in cells of the patient, and/or administering to the patient an antagonist of a retinol binding protein receptor (RBPr) and/or lowering the endogenous level of retinoic acid (RA) in cells of said patient.

REFERENCES:
patent: 4870101 (1989-09-01), Ku et al.
patent: 5438073 (1995-08-01), Saurat et al.
patent: 5858750 (1999-01-01), Bandman et al.
patent: 5917082 (1999-06-01), Vuligonda et al.
patent: 0284879 (1988-10-01), None
patent: 0610511 (1994-08-01), None
patent: 2023001 (1979-12-01), None
patent: WO 97/15298 (1999-05-01), None
patent: WO 01/30383 (2001-05-01), None
patent: WO 02/002074 (2002-01-01), None
patent: WO 02/072084 (2002-09-01), None
Napoli JL. “Retinol Metabolism in LLC-PK1 Cells. Characterization of Retinoic Acid Synthesis by an Established Mammalian Cell Line.” Journal of Biological Chemistry, 1986;261(29):13592-13597.
“Glucocorticoid”. Stedman's Medical Dictionary (Twenty-Second Edition). The Williams and Wilkins Company, 1972. p. 527.
Ghosh et al. “Mechanism of Inhibition of 3alpha,20beta-hydroxysteroid Dehydrogenase by a Licorice-Derived Steroidal Inhibitor”. Structure, Oct. 15, 1994; 2(10):973-980.
Kelloff et al. “Chemopreventive Drug Development: Perspectives and Progress”. Cancer Epidemiology, Biomarkers and Prevention. 3, 1994:85-98.
Bavik, Claes et al., “Retinol-Binding Protein Mediates Uptake of Retinol to Cultured Human Keratinocytes”,Exp. Cell Res., vol. 216, pp. 358-62 (1996).
Melhus, Hakan et al., “Epitope Mapping of a Monoclonal Antibody that Blocks the Binding of Retinol-Binding Protein to its Receptor”,Biochem. Biophys. Res. Comm., vol. 210, pp. 105-112 (1995).
Connor, M.J. “Modulation of Tumor Promotion in Mouse Skin by the Food Additive Citral (3,7-dimethyl-2,6-octadienal)”,Cancer Lett., vol. 56, pp. 25-28 (1991).
Estrov, Zeev et al., “Neoplasia: Phenylarsine Oxide Blocks Interleukin-1β-Induced Activation of the Nuclear Transcription Factor NF-kB, Inhibits Proliferation and Induces Apoptosis of Acute Myelogenous Leukemia Cells”,Blood, pp. 2844-2853 (1999).

Affiliated with

Also associated with

Rating

Treatment of hyperproliferative diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of hyperproliferative diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of hyperproliferative diseases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4253737